Previous studies have shown that IL-6, whose levels are increased in IBD [72,73,74,75], is linked to endothelial dysfunction, thrombocytosis, early atherosclerosis, and CAD [76,77,78,79]. Here, IL6 is linked to thrombocytosis disease.